First human test for potential lupus treatment begins
NCT ID NCT07408908
Summary
This is a very early-stage study to check the safety of a new drug called ACT100, which is being developed for lupus. It will be tested in 48 healthy volunteers to see how their bodies react to it and how the drug moves through their system. The main goal is to find a safe dose and understand the drug's basic effects before testing it in people who actually have lupus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.